Juvéderm Vollure XC from Allergan has been FDA cleared for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. The hyaluronic acid (HA)-based filler features the brand’s Vycross technology, which blends different molecular weights of HA for longer-lasting results. In the U.S. pivotal clinical trial, a majority of subjects saw improvement in moderate to severe nasolabial folds that lasted up to 18 months; 82% of subjects said they were very satisfied at six months and 68% were satisfied with their results at 18 months
Contact: 800.433.8871, www.juvederm.com.
Soft Tissue Filler: Juvederm Vollure XC
Jun 13th, 2017